Secondary stroke prevention in polish adults: Results from the lipidogram2015 study

- Labuz-Roszak, Beata, Banach, Maciej, Skrzypek, Michal, Windak, Adam, Charchar, Fadi

Title
Secondary stroke prevention in polish adults: Results from the lipidogram2015 study
Creator
Labuz-Roszak, Beata; Banach, Maciej; Skrzypek, Michal; Windak, Adam; Charchar, Fadi
Date
2021
Type
Text; Journal article
Identifier
http://researchonline.federation.edu.au/vital/access/HandleResolver/1959.17/180359
Identifier
vital:15735
Identifier
https://doi.org/10.3390/jcm10194472
Identifier
ISBN:2077-0383 (ISSN)
Abstract
Background: The purpose of the study was to evaluate secondary stroke prevention in Poland and its association with sociodemographic factors, place of residence, and concomitant cardiovascular risk factors. Material and methods: From all patients in LIPIDOGRAM2015 Study (n = 13,724), 268 subjects had a history of ischaemic stroke and were included. Results: 165 subjects (61.6%) used at least one preventive medication. Oral antiplatelet and anticoagulation agents were used by 116 (43.3%) and 70 (26.1%) patients, respectively. Only 157 (58.6%) participants used lipid-lowering drugs, and 205 (76.5%) were treated with antihypertensive drugs. Coronary heart disease (CHD) and dyslipidaemia were associated with antiplatelet treatment (p = 0.047 and p = 0.012, respectively). A history of atrial fibrillation, CHD, and previous myocardial infarction correlated with anticoagulant treatment (p = 0.001, p = 0.011, and p < 0.0001, respectively). Age, gender, time from stroke onset, place of residence, and level of education were not associated with antiplatelet or anticoagulant treatment. Only 31.7% of patients were engaged in regular physical activity, 62% used appropriate diet, and 13.6% were current smokers. Conclusions: In Poland drugs and lifestyle modification for secondary stroke prevention are not commonly adhered to. Educational programmes for physicians and patients should be developed to improve application of effective secondary prevention of stroke. © 2021 by the authors. **Please note that there are multiple authors for this article therefore only the name of the first 5 including Federation University Australia affiliate “Fadi Charchar” is provided in this record**
Publisher
MDPI
Relation
Journal of Clinical Medicine Vol. 10, no. 19 (2021), p.
Rights
All metadata describing materials held in, or linked to, the repository is freely available under a CC0 licence
Rights
https://creativecommons.org/licenses/by/4.0/
Rights
Copyright © 2021 by the authors
Rights
Open Access
Subject
1103 Clinical Sciences; Oral anticoagulant drugs; Oral antiplatelet drugs; Primary health care; Secondary stroke prevention
Full Text
Reviewed
Funder
The present study was an initiative of the Polish Lipid Association (PoLA) and the College of Family Physician in Poland (CFPiP). The present study was funded by an unrestricted educational grant from Valeant. As a supporter of the study, Valeant had no role in study design, data analysis, data interpretation, or writing of the report. The present study was also supported by Silesian Analytical Laboratories (SLA), CHDE, BIO‐RAD.
  • Hits: 828
  • Visitors: 783
  • Downloads: 100
Thumbnail File Description Size Format
SOURCE1 Published version 420 KB Adobe Acrobat PDF